Comparing NAL-NL1 and DSL v5 in Hearing Aids Fit to Children with Severe or Profound Hearing Loss: Goodness of Fit-to-Targets, Impacts on Predicted Loudness and Speech Intelligibility.
BACKGROUND
An important goal of providing amplification to children with hearing loss is to ensure that hearing aids are adjusted to match targets of prescriptive procedures as closely as possible. The Desired Sensation Level (DSL) v5 and the National Acoustic Laboratories' prescription for nonlinear hearing aids, version 1 (NAL-NL1) procedures are widely used in fitting hearing aids to children. Little is known about hearing aid fitting outcomes for children with severe or profound hearing loss.


OBJECTIVE
The purpose of this study was to investigate the prescribed and measured gain of hearing aids fit according to the NAL-NL1 and the DSL v5 procedure for children with moderately severe to profound hearing loss; and to examine the impact of choice of prescription on predicted speech intelligibility and loudness.


METHODS
Participants were fit with Phonak Naida V SP hearing aids according to the NAL-NL1 and DSL v5 procedures. The Speech Intelligibility Index (SII) and estimated loudness were calculated using published models.


METHODS
The sample consisted of 16 children (30 ears) aged between 7 and 17 yr old.


METHODS
The measured hearing aid gains were compared with the prescribed gains at 50 (low), 65 (medium), and 80 dB SPL (high) input levels. The goodness of fit-to-targets was quantified by calculating the average root-mean-square (RMS) error of the measured gain compared with prescriptive gain targets for 0.5, 1, 2, and 4 kHz. The significance of difference between prescriptions for hearing aid gains, SII, and loudness was examined by performing analyses of variance. Correlation analyses were used to examine the relationship between measures.


RESULTS
The DSL v5 prescribed significantly higher overall gain than the NAL-NL1 procedure for the same audiograms. For low and medium input levels, the hearing aids of all children fit with NAL-NL1 were within 5 dB RMS of prescribed targets, but 33% (10 ears) deviated from the DSL v5 targets by more than 5 dB RMS on average. For high input level, the hearing aid fittings of 60% and 43% of ears deviated by more than 5 dB RMS from targets of NAL-NL1 and DSL v5, respectively. Greater deviations from targets were associated with more severe hearing loss. On average, the SII was higher for DSL v5 than for NAL-NL1 at low input level. No significant difference in SII was found between prescriptions at medium or high input level, despite greater loudness for DSL v5 than for NAL-NL1.


CONCLUSIONS
Although targets between 0.25 and 2 kHz were well matched for both prescriptions in commercial hearing aids, gain targets at 4 kHz were matched for NAL-NL1 only. Although the two prescriptions differ markedly in estimated loudness, they resulted in comparable predicted speech intelligibility for medium and high input levels.
National Acoustic Laboratories, Sydney, New South Wales, Australia.
Teresa Y C
TY
Ching
School of Rehabilitation Sciences, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
Tian Kar
TK
Quar
Department of Audiology and Speech-Language Pathology, East Tennessee State University, Johnson City, TN, USA.|Mountain Home Veterans Affairs Medical Center, Mountain Home, TN, USA.
Earl E
EE
Johnson
Renwick Centre, Royal Institute for Deaf and Blind Children/University of Newcastle, New South Wales, Australia.
Philip
P
Newall
Department of Linguistics, Macquarie University, Sydney, New South Wales, Australia.
Mridula
M
Sharma
D000293:Adolescent; D001299:Audiometry; D002648:Child; D004867:Equipment Design; D005260:Female; D006310:Hearing Aids; D034381:Hearing Loss / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D008144:Loudness Perception / Q000502:physiology*; D008297:Male; D017755:Prosthesis Fitting; D013067:Speech Perception / Q000502:physiology*